Beauty / news
Estée Lauder Cos. Pledges $15 Million for Breast Cancer Research in Younger Women
The Estée Lauder Cos. has committed a $15 million, five-year grant to the Breast Cancer Research Foundation to launch the Global Research Initiative on Breast Cancer in Younger Women, billed as the largest coordinated global research program on early-onset disease.
The grant establishes the Global Research Initiative on Breast Cancer in Younger Women, a five-year commitment that will fund scientists worldwide studying the factors that drive early-onset breast cancer. Their work is set to focus on sharpening risk prediction, prevention, early detection and treatment approaches.
William P. Lauder, chairman of the board of the Estée Lauder Cos. and co-chair of the Breast Cancer Research Foundation, tied the donation to the company's long-running research efforts and to the legacy of his mother.
"The Estée Lauder Cos. has a long-standing commitment to advancing breast cancer research, and I know my mother would be so proud to see us carry her vision forward," Lauder said. He added that the funding would broaden understanding of the disease in younger women, "an area where there is still much to learn."
The foundation was founded by Evelyn H. Lauder in 1993. Since then, the company has directed more than $123 million to medical research through the organization, backing more than 400 research grants.
That funding includes support for what the company describes as the largest global study of breast cancer in Black women.